ImmunoPrecise Antibodies Ltd. (IPA)
NASDAQ: IPA · Real-Time Price · USD
3.200
+0.570 (21.67%)
At close: Aug 22, 2025, 4:00 PM
3.220
+0.020 (0.63%)
After-hours: Aug 22, 2025, 7:59 PM EDT

ImmunoPrecise Antibodies Stock Forecast

Stock Price Forecast

The 2 analysts that cover ImmunoPrecise Antibodies stock have a consensus rating of "Strong Buy" and an average price target of $4.00, which forecasts a 25.00% increase in the stock price over the next year. The lowest target is $3.00 and the highest is $5.00.

Price Target: $4.00 (+25.00%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$3.00$4.00$5.00$5.00
Change-6.25%+25.00%+56.25%+56.25%
* Price targets were last updated on Apr 11, 2025.

Analyst Ratings

The average analyst rating for ImmunoPrecise Antibodies stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingMar '25Apr '25May '25Jun '25Jul '25Aug '25
Strong Buy111111
Buy111111
Hold000000
Sell000000
Strong Sell000000
Total222222

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$5
Strong BuyReiterates$5+56.25%Apr 11, 2025
Benchmark
Benchmark
Buy
Reiterates
$3
BuyReiterates$3-6.25%Apr 1, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$7$5
Strong BuyMaintains$7$5+56.25%Mar 31, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$7
Strong BuyReiterates$7+118.75%Mar 14, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$9$7
Strong BuyMaintains$9$7+118.75%Dec 11, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
29.30M
from 24.52M
Increased by 19.47%
Revenue Next Year
38.70M
from 29.30M
Increased by 32.09%
EPS This Year
-0.11
from -0.91
EPS Next Year
0.02
from -0.11
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026FY 2027FY 2028
Period EndingApr 30, 2021Apr 30, 2022Apr 30, 2023Apr 30, 2024Apr 30, 2025Apr 30, 2026Apr 30, 2027Apr 30, 2028
Revenue
17.91M19.36M20.67M24.52M24.52M29.30M38.70M43.93M
Revenue Growth
27.42%8.11%6.72%18.65%0.01%19.47%32.09%13.51%
EPS
-0.45-0.85-1.07-1.02-0.91-0.110.02-
EPS Growth
--------
Forward PE
------219.22-
No. Analysts
-----222
Financial currency is CAD. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20262027202820292030
High30.5M40.2M45.7M
Avg29.3M38.7M43.9M
Low28.4M37.5M42.6M

Revenue Growth

Revenue Growth20262027202820292030
High
24.2%
37.3%
18.0%
Avg
19.5%
32.1%
13.5%
Low
15.9%
28.2%
10.1%

EPS Forecast

EPS20262027
High-0.120.02
Avg-0.110.02
Low-0.110.02

EPS Growth

EPS Growth20262027
High--
Avg--
Low--
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.